We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$74.4B
AUM Growth
+$7.26B
(+11%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,535
Reduced
421
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$141M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$96.6M |
| 4 |
Amazon
AMZN
|
+$63.7M |
| 5 |
Prologis
PLD
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$56.3M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$36M |
| 3 |
Y
Alleghany Corp
Y
|
+$33M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$26.6M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Healthcare | 14.94% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 10% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
2201
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $881K | ﹤0.01% |
30,127
-724
| -2% | -$23K |
|
2202
Planet Labs
PL
$8.53B
| $880K | ﹤0.01% |
202,241
+1,277
| +0.6% | +$6.61K |
|
2203
Montauk Renewables
MNTK
$255M
| $878K | ﹤0.01% |
79,613
+1,204
| +2% | +$16.1K |
|
|
CATC
2204
DELISTED
CAMBRIDGE BANCORP
CATC
| $878K | ﹤0.01% |
10,575
+38
| +0.4% | +$3.25K |
|
|
TWKS
2205
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $876K | ﹤0.01% |
85,932
+781
| +0.9% | +$7.25K |
|
2206
Gorman-Rupp
GRC
$2.21B
| $873K | ﹤0.01% |
34,057
-12
| -0% | -$317 |
|
2207
Arlo Technologies
ARLO
$1.65B
| $870K | ﹤0.01% |
247,781
+8,778
| +4% | +$36.1K |
|
2208
Playtika
PLTK
$1.12B
| $870K | ﹤0.01% |
102,256
-3,066
| -3% | -$28.4K |
|
|
FRG
2209
DELISTED
Franchise Group, Inc.
FRG
| $870K | ﹤0.01% |
36,542
+1,045
| +3% | +$27.3K |
|
2210
Ennis
EBF
$564M
| $869K | ﹤0.01% |
39,197
+292
| +0.8% | +$6.48K |
|
2211
Quanterix
QTRX
$190M
| $868K | ﹤0.01% |
62,689
+11,600
| +23% | +$133K |
|
|
CTIC
2212
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $868K | ﹤0.01% |
144,396
+2,481
| +2% | +$13.5K |
|
2213
Goosehead Insurance
GSHD
$2.32B
| $866K | ﹤0.01% |
25,217
+860
| +4% | +$32.2K |
|
|
CFB
2214
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $863K | ﹤0.01% |
69,550
+93
| +0.1% | +$1.24K |
|
|
PRVB
2215
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $859K | ﹤0.01% |
81,291
+6,427
| +9% | +$51.9K |
|
|
ZYXI
2216
DELISTED
Zynex
ZYXI
| $857K | ﹤0.01% |
61,643
-76
| -0.1% | -$919 |
|
|
FSP
2217
Franklin Street Properties
FSP
$46.8M
| $853K | ﹤0.01% |
312,377
+3,625
| +1% | +$10K |
|
|
PAYA
2218
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $853K | ﹤0.01% |
108,340
+2,955
| +3% | +$22.8K |
|
2219
Ducommun
DCO
$2.98B
| $852K | ﹤0.01% |
17,056
+16
| +0.1% | +$762 |
|
|
NUVL
2220
DELISTED
Nuvalent
NUVL
| $852K | ﹤0.01% |
28,620
+3,611
| +14% | +$101K |
|
|
CNSL
2221
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $849K | ﹤0.01% |
237,123
+4,681
| +2% | +$20.8K |
|
2222
OneSpaWorld
OSW
$2.66B
| $848K | ﹤0.01% |
90,915
+11,827
| +15% | +$112K |
|
|
VRAY
2223
DELISTED
ViewRay, Inc.
VRAY
| $847K | ﹤0.01% |
188,956
+4,800
| +3% | +$20.9K |
|
|
KE
2224
Kimball Electronics
KE
$628M
| $846K | ﹤0.01% |
37,447
+241
| +0.6% | +$5.16K |
|
2225
Amplitude
AMPL
$1.41B
| $844K | ﹤0.01% |
69,876
+920
| +1% | +$13K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,535 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.
- RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
- RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
- RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
- RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
- RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
- RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.